76471856 - PROBIODRUG

Information

• Trademark
• 76471856

• Source

• Serial Number

  76471856

• Registration Number

  2833852

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 20, 2002
  22 years ago

• Registration Date

  April 20, 2004
  20 years ago

• Transaction Date

  July 22, 2011
  13 years ago

• Status Date

  November 26, 2010
  13 years ago

• Published for Opposition Date

  January 27, 2004
  20 years ago

• Location Date

  May 18, 2004
  20 years ago

• Status Code

  710

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  SMITH, BRIDGETT G

• Attorney Docket Number

  DT-6349

  Attorney Name

  David Toren

  Law Office Assigned Location Code

  M60

• Owners

  • Probiodrug (AG)

Case File Statements

• GS0011: Chemical preparations for the use in the manufacture of pharmaceuticals for the treatment of type 2 diabetes, impaired glucose tolerance, glucosuria, and disturbances of signal action at the cells of the islets of Langerhans and insulin sensitivity in the peripheral tissue in the postprandial phase of mammals, insulin resistance, metabolic acidosis, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus, diabetes mellitus type 1, lipid disorders, hyperlipidemia, metabolism-related hypertension and cardiovascular sequelae caused by hypertension in mammals, atherosclerosis and its sequelae, inflammatory bowel disease, namely, Crohn's disease and ulcerative colitis, pancreatitis, tumor metastasis, benign prostatic hypertrophy, gingivitis, osteoporosis, for the prophylaxis or treatment of skin diseases and diseases of the mucosae, autoimmune diseases and inflammatory conditions, and for the prophylaxis or treatment of psychosomatic, neuropsychiatric and depressive illness, and neurodegenerative diseases namely anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, nutritional disorders, spasm, and chronic pain, multiple sclerosis, Alzheimer's disease, Down Syndrome, and for use in the manufacture of contraceptive drugs for scientific, medical and biological purposes, diagnostic preparations and reagents for use in scientific and medical research
• GS0051: Pharmaceutical preparations for the treatment of non-insulin dependent diabetes mellitus (type 2), impaired glucose tolerance, glucosuria, and disturbances of signal action at the cells of the islets of Langerhans and insulin sensitivity in the peripheral tissue in the postprandial phase of mammals, insulin resistance, metabolic acidosis, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus, diabetes mellitus type 1, lipid disorders, hyperlipidemia, metabolism-related hypertension and cardiovascular sequelae caused by hypertension in mammals; pharmaceutical preparations for the treatment of atherosclerosis and its sequelae, inflammatory bowel disease, namely, Crohn's disease and ulcerative colitis, pancreatitis, tumor metastasis, benign prostatic hypertrophy, gingivitis, osteoporosis; pharmaceutical preparations for the prophylaxis or treatment of skin diseases and diseases of the mucosae, autoimmune diseases and inflammatory conditions, and for the prophylaxis or treatment of psychosomatic, neuropsychiatric and depressive illness, and neurodegenerative diseases namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, nutritional disorders, spasm, and chronic pain, multiple sclerosis, Alzheimer's disease; Veterinary preparations for the treatment of metabolic diseases, cancerous diseases, psychosomatic, neuropsychiatric, depressive and neurodegenerative diseases in livestock and domestic animals; All purpose disinfectants, diagnostic reagents for clinical or medical use; Dietary supplements, food for enteral feeding; Agrochemicals, namely fungicides, herbicides and insecticides for agricultural and domestic use
• GS0101: surgical, medical, dental and veterinary instruments and apparatus, namely electronic monitors, recorders and analyzers for blood pressure, blood analysis, blood glucose, insulin in the blood, pH Monitors
• GS0411: educational services, namely conducting classes, seminars, conferences and workshops in the field of human medicine, veterinary medicine, human nutrition, pet nutrition and agriculture
• GS0421: Chemist, physicist, microbiologist, biologist and Chemical, biological and medical research in the field of drugs and genetic engineering
• PM0000: PROBIO DRUG

Case File Event Statements

• 11/26/2010 - 13 years ago

  16 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 7/6/2006 - 18 years ago

  15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/20/2004 - 20 years ago

  14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/13/2003 - 21 years ago

  13 - PAPER RECEIVED Type: MAIL

• 1/27/2004 - 20 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/7/2004 - 20 years ago

  11 - NOTICE OF PUBLICATION Type: NPUB

• 11/25/2003 - 20 years ago

  10 - Sec. 1(B) CLAIM DELETED Type: 1.BD

• 11/14/2003 - 21 years ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/27/2003 - 21 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/23/2003 - 21 years ago

  7 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 6/16/2003 - 21 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/2/2003 - 21 years ago

  5 - CASE FILE IN TICRS Type: CFIT

• 6/16/2003 - 21 years ago

  4 - PAPER RECEIVED Type: MAIL

• 3/24/2003 - 21 years ago

  3 - NON-FINAL ACTION MAILED Type: CNRT

• 3/12/2003 - 21 years ago

  2 - ASSIGNED TO EXAMINER Type: DOCK

• 1/31/2003 - 21 years ago

  1 - PAPER RECEIVED Type: MAIL